Titan Biotech Limited (BOM:524717)

India flag India · Delayed Price · Currency is INR
452.60
-15.80 (-3.37%)
At close: Apr 28, 2026
375.17%
Market Cap 19.60B
Revenue (ttm) 1.93B
Net Income (ttm) 272.03M
Shares Out 41.32M
EPS (ttm) 6.58
PE Ratio 72.07
Forward PE n/a
Dividend 0.40 (0.09%)
Ex-Dividend Date Sep 19, 2025
Volume 65,444
Average Volume 108,655
Open 467.85
Previous Close 468.40
Day's Range 445.00 - 467.85
52-Week Range 74.73 - 555.65
Beta -0.48
RSI 53.95
Earnings Date May 29, 2026

About Titan Biotech

Titan Biotech Limited engages in the manufacture and sale of biological products in India and internationally. It offers food ingredients, including hydrolyzed vegetable protein, yeast extract powder, calcium propionate powder, potassium sorbate, and calcium lactate; collagen and protein products, such as wheat hydrolysate protein, corn hydrolysate protein, bovine collagen peptide, collagen peptide, fish collage, undernatured chicken collagen type II, mucopolysaccharides, chicken protein isolate, soya protein isolate, and pea protein isolate; a... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1992
Employees 467
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524717
Full Company Profile

Financial Performance

In fiscal year 2025, Titan Biotech's revenue was 1.56 billion, a decrease of -4.65% compared to the previous year's 1.64 billion. Earnings were 215.32 million, a decrease of -13.36%.

Financial Statements

News

There is no news available yet.